115 related articles for article (PubMed ID: 359460)
1. Effect of delta9-tetrahydrocannabinol on in vitro sensitization of mouse splenic lymphocytes.
Lefkowitz SS; Klager K
Immunol Commun; 1978; 7(5):557-66. PubMed ID: 359460
[TBL] [Abstract][Full Text] [Related]
2. Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol.
Springs AE; Karmaus PW; Crawford RB; Kaplan BL; Kaminski NE
J Leukoc Biol; 2008 Dec; 84(6):1574-84. PubMed ID: 18791168
[TBL] [Abstract][Full Text] [Related]
3. Hyporesponsiveness to the immunosuppressant effects of delta-8-tetrahydrocannabinol.
Loveless SE; Harris LS; Munson AE
J Immunopharmacol; 1981-1982; 3(3-4):371-83. PubMed ID: 6290570
[TBL] [Abstract][Full Text] [Related]
4. Delta 9-tetrahydrocannabinol selectively inhibits T-cell dependent humoral immune responses through direct inhibition of accessory T-cell function.
Schatz AR; Koh WS; Kaminski NE
Immunopharmacology; 1993; 26(2):129-37. PubMed ID: 8282537
[TBL] [Abstract][Full Text] [Related]
5. Influence of adrenaline on the dissemination of antibody-producing cells from the spleen.
Ernström U; Söder O
Clin Exp Immunol; 1975 Jul; 21(1):131-40. PubMed ID: 1102159
[TBL] [Abstract][Full Text] [Related]
6. delta1-tetrahydrocannabinol, cannabidiol and cannabinol effects on the immune response of mice.
Zimmerman S; Zimmerman AM; Cameron IL; Laurence HL
Pharmacology; 1977; 15(1):10-23. PubMed ID: 320608
[TBL] [Abstract][Full Text] [Related]
7. Increase in the number of splenic plaque forming cells with length of gestation in untreated pregnant mice.
Mattsson R
Dev Comp Immunol; 1982; 6(2):339-48. PubMed ID: 7047249
[TBL] [Abstract][Full Text] [Related]
8. Examination of the immunosuppressive effect of delta9-tetrahydrocannabinol in streptozotocin-induced autoimmune diabetes.
Li X; Kaminski NE; Fischer LJ
Int Immunopharmacol; 2001 Apr; 1(4):699-712. PubMed ID: 11357882
[TBL] [Abstract][Full Text] [Related]
9. Nonspecific elicitation of antibody-forming cells in the mouse spleen by bacterial lipopolysaccharide.
Nakano M; Uchiyama T; Tanabe MJ; Saito K
Jpn J Microbiol; 1975 Apr; 19(2):141-8. PubMed ID: 1097768
[TBL] [Abstract][Full Text] [Related]
10. Modification of immune response in nude mice infected with mouse hepatitis virus.
Tamura T; Machii K; Ueda K; Fujiwara K
Microbiol Immunol; 1978; 22(9):557-64. PubMed ID: 215883
[TBL] [Abstract][Full Text] [Related]
11. The immune response of mice treated with anti-mu antibodies: the effect on antibody-forming cells, their precursors and helper cells assayed in vitro.
Gordon J; Murgita RA; Tomasi TB
J Immunol; 1975 Jun; 114(6):1808-12. PubMed ID: 805179
[TBL] [Abstract][Full Text] [Related]
12. Facb rosette-forming cells in mice: studies on their functional significance.
Eales LJ; Hall ND; Hunneyball IM
Immunology; 1984 May; 52(1):17-24. PubMed ID: 6201437
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of antibody synthesizing lymphocytes in the rat by antigen reactive cells sensitized in vitro.
Rabin BS; Lombardi B
Proc Soc Exp Biol Med; 1976 Apr; 151(4):766-9. PubMed ID: 1083533
[TBL] [Abstract][Full Text] [Related]
14. Specific immunosuppression without genetic restriction on IgM PFC by primed spleen homogenate.
Yamaguchi H; Kinjo K
Kobe J Med Sci; 1980 Mar; 26(1):73-87. PubMed ID: 6993782
[No Abstract] [Full Text] [Related]
15. A study of the mechanism of Con A-induced immunosuppression in vivo.
Smith SR; Umland S; Terminelli C; Watnick AS
Cell Immunol; 1984 Aug; 87(1):147-58. PubMed ID: 6234994
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the immune response of mouse spleen cells to sheep erythrocytes in vitro by anti-immunoglobulin sera.
Sjöberg O; Greaves M
Eur J Immunol; 1971 Jun; 1(3):157-62. PubMed ID: 4108346
[No Abstract] [Full Text] [Related]
17. Cells involved in the immune response. XXXIV: Suppressor cells in the thymus of the immunized rabbit capable of secreting a factor which can suppress the secretion of antibodies from antibody-forming cells in vitro.
Richter M; Talor E
Clin Immunol Immunopathol; 1986 Dec; 41(3):461-78. PubMed ID: 2430747
[TBL] [Abstract][Full Text] [Related]
18. The potentiality of antibody-producing cells. II. Evidence for two antibody molecules of different specificities secreted by micromanipulated bispecific mouse spleen cells.
Couderg J; Bleux C; Liacopoulos P
Immunology; 1975 Oct; 29(4):665-74. PubMed ID: 52617
[TBL] [Abstract][Full Text] [Related]
19. Antibody plaque reduction in vitro and in vivo: a rapid assay for immunosuppressive agents.
Gavin J; Waterbury W; Freidman H
Transplant Proc; 1969 Mar; 1(1):413-5. PubMed ID: 4944252
[No Abstract] [Full Text] [Related]
20. Effects of allogenic and effector cells on the development of antibody-producing cells, in vitro.
Pazdernik TL; Uyeki DM
Proc Soc Exp Biol Med; 1975 Dec; 150(3):654-9. PubMed ID: 1108041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
